Steven Cohen Reata Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $16.2 Million - $21.5 Million	204,051 Added 56.04%	568,151 $57.9 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $11.2 Million - $33.9 Million	364,100 New	364,100 $33.1 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $35.1 Million - $66.1 Million	1,810,647 New	1,810,647 $45.5 Million
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $4.6 Million - $8.9 Million	-58,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $1.68 Million - $2.36 Million	17,800 Added 43.41%	58,800 $5.86 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $4.18 Million - $7.57 Million	41,000 New	41,000 $5.07 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $13.7 Million - $24 Million	-146,938 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $3.71 Million - $5.18 Million	-29,360 Reduced 16.65%	146,938 $22.9 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $6.46 Million - $12.9 Million	-52,002 Reduced 22.78%	176,298 $25.4 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $9.83 Million - $28.7 Million	-131,788 Reduced 36.6%	228,300 $46.7 Million
Q3 2019 Nov 15, 2019	BUY	$71.26 - $95.75 $3.05 Million - $4.1 Million	42,788 Added 13.49%	360,088 $28.9 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $2.08 Million - $2.52 Million	26,700 Added 9.19%	317,300 $29.9 Million
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $550,140 - $1.08 Million	-10,600 Reduced 3.52%	290,600 $24.8 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $21.9 Million - $34.3 Million	-448,600 Reduced 59.83%	301,200 $16.9 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $19.6 Million - $50.7 Million	550,706 Added 276.61%	749,800 $61.3 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $3.97 Million - $8.15 Million	199,094 New	199,094 $6.96 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account